Aristides Capital LLC Takes $249,000 Position in Option Care Health, Inc. $OPCH

Aristides Capital LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 7,681 shares of the company’s stock, valued at approximately $249,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of OPCH. USA Financial Formulas acquired a new stake in shares of Option Care Health during the 2nd quarter valued at about $26,000. Northwestern Mutual Wealth Management Co. lifted its stake in Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares during the period. Elevation Point Wealth Partners LLC acquired a new stake in Option Care Health during the second quarter valued at approximately $40,000. Brooklyn Investment Group boosted its holdings in Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock valued at $42,000 after purchasing an additional 780 shares in the last quarter. Finally, Wealthquest Corp bought a new stake in shares of Option Care Health in the 1st quarter valued at approximately $66,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 0.6%

Shares of NASDAQ OPCH opened at $31.02 on Thursday. Option Care Health, Inc. has a 1-year low of $22.29 and a 1-year high of $35.53. The company has a 50-day moving average of $27.87 and a two-hundred day moving average of $29.41. The company has a market cap of $4.92 billion, a PE ratio of 24.82, a P/E/G ratio of 1.74 and a beta of 0.88. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the firm’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the transaction, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Norman L. Wright bought 3,411 shares of the company’s stock in a transaction dated Tuesday, September 9th. The shares were purchased at an average price of $29.31 per share, with a total value of $99,976.41. Following the transaction, the director owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on OPCH shares. JMP Securities set a $36.00 target price on Option Care Health in a report on Friday, October 31st. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Morgan Stanley started coverage on shares of Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price on the stock. Citizens Jmp lowered their target price on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a report on Friday, October 31st. Finally, Cowen initiated coverage on shares of Option Care Health in a report on Thursday, October 2nd. They set a “hold” rating for the company. Nine analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $35.67.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.